Literature DB >> 3356216

Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor.

L J Schelfhout1, C L Creutzberg, J F Hamming, G J Fleuren, D Smeenk, J Hermans, C J van de Velde, B M Goslings.   

Abstract

A retrospective analysis of tumour and patient characteristics was performed in 202 patients with papillary (n = 132) or follicular (n = 70) thyroid carcinoma, in order to identify prognostic factors related to survival. The following facts were found to be unfavourably related to survival: follicular histology, extrathyroidal growth of the primary tumour (stage pT4), regional lymph node involvement (stages pN1-3), presence of distant metastases at diagnosis (stage pM1), male sex (in papillary cancer) and old age (only death due to thyroid tumour was evaluated). For 190 patients sufficient material was available to permit extensive histopathological investigation. In patients with papillary cancer the presence of small anaplastic foci and/or greater than 25% solid structures (n = 18) was correlated with a reduced survival rate. Our study underlines the importance of distinguishing, histologically, between papillary and follicular cancer and in addition demonstrates the prognostic value of histological grade in papillary (but not follicular) carcinoma. We applied Cox's proportional hazard model to the survival data of these 190 patients and, after stage grouping, found that tumour stage (locoregional vs. advanced disease) was the most important prognostic factor. The second most important factor was the histological (sub)type (well differentiated papillary carcinoma vs. moderately differentiated papillary carcinoma and follicular carcinoma). Age at diagnosis and sex appeared to be of lesser importance. Therefore our study does not recommend the use of age as a guide for therapeutical decisions in differentiated thyroid cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3356216     DOI: 10.1016/0277-5379(88)90276-3

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  13 in total

Review 1.  Thyroid cancer in children and adolescents.

Authors:  Furio Pacini
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.

Authors:  Jürgen Witte; Steffen Lehmann; Michael Wulfert; Quin Yang; Hans D Röher
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 3.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

4.  Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.

Authors:  J F Hamming; L J Schelfhout; C J Cornelisse; C J van de Velde; B M Goslings; J Hermans; G J Fleuren
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

5.  [Prognostically relevant factors in follicular thyroid cancer].

Authors:  T Böttger; J Klupp; K Sorger; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1990

Review 6.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

7.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

Review 8.  Papillary thyroid cancer.

Authors:  J H Yim; G M Doherty
Journal:  Curr Treat Options Oncol       Date:  2000-10

9.  Multivariate analysis of risk factors influencing survival in 110 ethnic Chinese with papillary thyroid cancer.

Authors:  T G Lorentz; P W Lau; C Y Lo; W L Law; K Y Wan; I J Lauder
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  Prognostic factors associated with differentiated thyroid cancer.

Authors:  A Tsuchiya; S Suzuki; M Kanno; Y Kikuchi; Y Ando; R Abe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.